Bischheim, France

Regine Bartsch


Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Bischheim, FR (1995)
  • Fontenay aux Roses, FR (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Regine Bartsch: Innovator in Neuroprotective Compounds

Introduction

Regine Bartsch is a prominent inventor based in Bischheim, France. She has made significant contributions to the field of neuroprotective compounds, holding two patents that showcase her innovative work. Her research focuses on developing compounds that can aid in the treatment of cerebral disorders.

Latest Patents

Regine Bartsch's latest patents include N-(3-Aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide, which presents a range of compounds useful in treating cerebral disorders. Another notable patent involves benzoxazine derivatives, which are recognized for their neuroprotective and anti-ischemic properties. These compounds are designed to enhance therapeutic applications in the medical field.

Career Highlights

Throughout her career, Regine has been associated with Synthelabo, where she has contributed to groundbreaking research in neuropharmacology. Her work has been instrumental in advancing the understanding of compounds that can protect the nervous system and improve patient outcomes.

Collaborations

Regine Bartsch has collaborated with notable colleagues, including Jonathan Reid Frost and Pascal George. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of neuroprotective research.

Conclusion

Regine Bartsch's contributions to the field of neuroprotective compounds highlight her role as an influential inventor. Her patents reflect her commitment to advancing medical science and improving therapeutic options for patients with cerebral disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…